Irish Genomics Research Co. Inks $400M Investment
Irish genetics research company Genomics Medicine Ireland on Tuesday unveiled plans to reap $400 million from investors, including Singapore's state-run investment firm Temasek and an Irish sovereign development fund, in an...To view the full article, register now.
Already a subscriber? Click here to view full article